Cost－ effectiveness Analysis of Therapeutic schemes for Peptic Ulcer With Helicobacteria Pylori
- VernacularTitle:幽门螺旋杆菌感染致消化性溃疡治疗的成本－效果分析
- Author:
Qinyun ZHENG
;
Yanle QI
;
Guanyang LIN
- Publication Type:Journal Article
- From:
China Pharmacy
2001;12(5):282-283
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE： To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes（ including A， B and C schemes） for peptic ulcer with Helicobacteria pylori were compared METHODS： The schemes were evaluated with pharmacoeconomic cost－ effectiveness analysis RESULTS： The results showed that B was the best scheme from either cost－ effectiveness analysis（ C/E） or increasing costeffectiveness analysis（ Δ C/Δ E） CONCLUSION： Pharmacoeconomics is very important in optimizing therapeutic scheme， guiding rational drug use and in_ creasing economic effectiveness
